Publications

Found 3 results
Filters: Keyword is Prognosis  [Clear All Filters]
2019
Yap TA, Winter JN, Giulino-Roth L, Longley J, Lopez J, Michot J-M, Leonard JP, Ribrag V, McCabe MT, Creasy CL et al..  2019.  Phase I Study of the Novel Enhancer of Zeste Homolog 2 (EZH2) Inhibitor GSK2816126 in Patients with Advanced Hematologic and Solid Tumors.. Clin Cancer Res. 25(24):7331-7339.
2018
Giulino-Roth L, O'Donohue T, Chen Z, Trippett TM, Klein E, Kernan NA, Kobos R, Prockop SE, Scaradavou A, Shukla N et al..  2018.  Outcome of children and adolescents with relapsed Hodgkin lymphoma treated with high-dose therapy and autologous stem cell transplantation: the Memorial Sloan Kettering Cancer Center experience.. Leuk Lymphoma. 59(8):1861-1870.
2017
Giulino-Roth L, O'Donohue T, Chen Z, Bartlett NL, LaCasce A, Martin-Doyle W, Barth MJ, Davies K, Blum KA, Christian B et al..  2017.  Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R.. Br J Haematol. 179(5):739-747.